2010
DOI: 10.1016/s0016-5085(10)60651-8
|View full text |Cite
|
Sign up to set email alerts
|

967 The CB1 Receptor Antagonist Rimonabant Suppresses Gastric Interdigestive Motility and Hunger Pangs in Healthy Volunteers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…After Roux‐en‐Y gastric bypass surgery, motilin, but not ghrelin plasma levels decreased in parallel with lower hedonic hunger scores 50 . In a preliminary report, endocannabinoid type 1 receptor antagonist rimonabant was also found to inhibit gastric phase III and the associated hunger peaks 51 …”
Section: Gastrointestinal Signals Involved In Determining the Return Of Hungermentioning
confidence: 96%
See 1 more Smart Citation
“…After Roux‐en‐Y gastric bypass surgery, motilin, but not ghrelin plasma levels decreased in parallel with lower hedonic hunger scores 50 . In a preliminary report, endocannabinoid type 1 receptor antagonist rimonabant was also found to inhibit gastric phase III and the associated hunger peaks 51 …”
Section: Gastrointestinal Signals Involved In Determining the Return Of Hungermentioning
confidence: 96%
“…50 In a preliminary report, endocannabinoid type 1 receptor antagonist rimonabant was also found to inhibit gastric phase III and the associated hunger peaks. 51 The mechanisms controlling the release of motilin from duodenal entero-endocrine cells in health and disease are poorly understood and need to be studied in further detail. Fasting antral contractility episodes (MMCs) are reduced to zero over a period of 4 h after GLP-1 infusion in healthy volunteers.…”
Section: Motilin-induced Gastric Phase III As a Determinant Of The Return Of Hunger After A Mealmentioning
confidence: 99%